SL

Siren LLC Portfolio holdings

AUM $2.56B
1-Year Est. Return 159.09%
This Quarter Est. Return
1 Year Est. Return
+159.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.56B
AUM Growth
+$624M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
133
New
Increased
Reduced
Closed

Top Buys

1 +$45.8M
2 +$28.8M
3 +$21.2M
4
RAPP
Rapport Therapeutics
RAPP
+$20M
5
RELY icon
Remitly
RELY
+$18M

Top Sells

1 +$44.9M
2 +$25.8M
3 +$24M
4
AKRO
Akero Therapeutics
AKRO
+$17M
5
TRVI icon
Trevi Therapeutics
TRVI
+$12.8M

Sector Composition

1 Healthcare 91.03%
2 Technology 5.1%
3 Communication Services 1.94%
4 Consumer Discretionary 0.86%
5 Real Estate 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEMR icon
101
Semrush
SEMR
$1.77B
$885K 0.03%
125,000
AS icon
102
Amer Sports
AS
$21.3B
$869K 0.03%
+25,000
PINS icon
103
Pinterest
PINS
$17.6B
$804K 0.03%
+25,000
FIG
104
Figma
FIG
$17.9B
$778K 0.03%
+15,000
CFLT icon
105
Confluent
CFLT
$10.6B
$743K 0.03%
+37,500
PCOR icon
106
Procore
PCOR
$11.6B
$729K 0.03%
10,000
ALAB icon
107
Astera Labs
ALAB
$25.1B
$685K 0.03%
+3,500
TSLA icon
108
Tesla
TSLA
$1.53T
$667K 0.03%
1,500
-2,500
CHYM
109
Chime Financial
CHYM
$9.81B
$504K 0.02%
+25,000
CCC
110
CCC Intelligent Solutions
CCC
$4.92B
$456K 0.02%
50,000
KVUE icon
111
Kenvue
KVUE
$33.2B
$406K 0.02%
+25,000
VRT icon
112
Vertiv
VRT
$61.7B
$302K 0.01%
2,000
CYCN icon
113
Cyclerion Therapeutics
CYCN
$5.75M
$267K 0.01%
116,155
CRBU icon
114
Caribou Biosciences
CRBU
$167M
$245K 0.01%
105,347
IRWD icon
115
Ironwood Pharmaceuticals
IRWD
$582M
$145K 0.01%
110,532
PCVX icon
116
Vaxcyte
PCVX
$5.83B
-295,543
RCKT icon
117
Rocket Pharmaceuticals
RCKT
$367M
-591,263
TEAM icon
118
Atlassian
TEAM
$42.6B
-3,500
TRML
119
DELISTED
Tourmaline Bio
TRML
-91,426
UNH icon
120
UnitedHealth
UNH
$310B
-5,076
VERA icon
121
Vera Therapeutics
VERA
$3.54B
-247,216
VIGL
122
DELISTED
Vigil Neuroscience
VIGL
-411,191
RDDT icon
123
Reddit
RDDT
$42.6B
-2,000
AKRO
124
DELISTED
Akero Therapeutics
AKRO
-318,647
APGE icon
125
Apogee Therapeutics
APGE
$5.27B
-594,994